HE homepage

Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.

AI continues to make strides in medicine, with an expected market size in excess of $13 billion by 2025. But physicians and medical school deans at the Imagine Solutions Conference in Naples, Florida, stressed there is no substitute for the patient-physician relationship. 

A CMS report found the problems at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida, were more extensive than the pediatric heart unit, The Tampa Bay Times reported.

A new machine learning model allows for physicians to determine whether atypical ductal hyperplasia (ADH) could upgrade to cancer, according to new research published in JCO Clinical Cancer Informatics. The model can identify 98 percent of all malignant cases prior to surgery, while sparing 16 percent of women from unnecessary surgeries. 

Niramai Health Analytix, an AI-based diagnostic company, has raised $6 million in funding for its tool that leverages AI to screen for early stage breast cancer.

General Electric Company (GE) is selling its biopharma business to Danaher for $21.4 billion, the company announced Feb. 25. With a definitive agreement signed between the two parties, GE’s previous plan to spin off its healthcare sector with its own initial public offering is likely put on hold, GE Chairman and CEO Larry Culp told CNBC.

Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.

Drug middlemen gobbled up $123.5 million in hidden costs in Kentucky’s Medicaid program, according to a new report from the Kentucky’s Cabinet for Health and Family Services.

Around the web

The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.